Published in Mol Cell Endocrinol on August 28, 2008
Sex differences in human adipose tissues - the biology of pear shape. Biol Sex Differ (2012) 1.64
Feed-forward inhibition of androgen receptor activity by glucocorticoid action in human adipocytes. Chem Biol (2012) 1.47
Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells. BMC Med (2013) 1.33
Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev (2013) 1.33
Temporal profiling of the secretome during adipogenesis in humans. J Proteome Res (2010) 1.07
Nuclear receptor regulation of stemness and stem cell differentiation. Exp Mol Med (2009) 1.03
Selective androgen receptor modulators as function promoting therapies. Curr Opin Clin Nutr Metab Care (2009) 0.98
Testosterone and the cardiovascular system: a comprehensive review of the basic science literature. J Am Heart Assoc (2013) 0.96
Identification of a clinically relevant androgen-dependent gene signature in prostate cancer. Cancer Res (2011) 0.94
Androgens inhibit adipogenesis during human adipose stem cell commitment to preadipocyte formation. Steroids (2013) 0.93
Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss. Clin Obes (2013) 0.92
Lowered testosterone in male obesity: mechanisms, morbidity and management. Asian J Androl (2014) 0.91
Testosterone and the cardiovascular system: a comprehensive review of the clinical literature. J Am Heart Assoc (2013) 0.89
Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation. J Cell Biochem (2011) 0.89
Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal cultures. Prostate (2016) 0.80
Bioactive androgens and glucuronidated androgen metabolites are associated with subcutaneous and ectopic skeletal muscle adiposity among older black men. Metabolism (2011) 0.80
Skin aging: are adipocytes the next target? Aging (Albany NY) (2016) 0.79
Mitochondrial DNA polymerase editing mutation, PolgD257A, reduces the diabetic phenotype of Akita male mice by suppressing appetite. Proc Natl Acad Sci U S A (2011) 0.78
Loss of androgen receptor promotes adipogenesis but suppresses osteogenesis in bone marrow stromal cells. Stem Cell Res (2013) 0.78
Hematopoietic androgen receptor deficiency promotes visceral fat deposition in male mice without impairing glucose homeostasis. Andrology (2015) 0.77
Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism? Ther Adv Urol (2015) 0.77
Association of androgen with gender difference in serum adipocyte fatty acid binding protein levels. Sci Rep (2016) 0.77
Effects of anabolic-androgens on brain reward function. Front Neurosci (2015) 0.77
Stem cell activation in adults can reverse detrimental changes in body composition to reduce fat and increase lean mass in both sexes. J Cell Biochem (2011) 0.77
Association between serum total testosterone and Body Mass Index in middle aged healthy men. Pak J Med Sci (2015) 0.75
Cause of androgenic alopecia: crux of the matter. Plast Reconstr Surg Glob Open (2013) 0.75
Effect of Dehydroepiandrosterone and Testosterone Supplementation on Systemic Lipolysis. J Clin Endocrinol Metab (2016) 0.75
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods (1983) 114.35
Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA (2006) 7.09
Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2006) 5.58
Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism (2001) 3.25
Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis. Obes Res (2004) 3.05
Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am J Physiol Endocrinol Metab (2006) 3.03
Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab (2004) 3.02
Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis. Anal Bioanal Chem (2003) 2.87
Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab (1999) 2.79
Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab (2000) 2.68
Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab (1996) 2.30
Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am J Physiol Regul Integr Comp Physiol (2002) 2.23
Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab (2000) 2.17
Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. Am J Physiol Endocrinol Metab (2004) 2.16
Transcriptional control of adipogenesis. Annu Rev Nutr (2000) 2.14
The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord (1996) 2.13
Adipocyte differentiation: from fibroblast to endocrine cell. Exp Biol Med (Maywood) (2001) 2.07
Fat depot-specific characteristics are retained in strains derived from single human preadipocytes. Diabetes (2006) 1.99
Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf) (2005) 1.90
Aging in adipocytes: potential impact of inherent, depot-specific mechanisms. Exp Gerontol (2007) 1.81
Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology (2003) 1.74
Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism (1990) 1.63
The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord (1992) 1.61
Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) (2006) 1.38
The effects of myostatin on adipogenic differentiation of human bone marrow-derived mesenchymal stem cells are mediated through cross-communication between Smad3 and Wnt/beta-catenin signaling pathways. J Biol Chem (2008) 1.32
Lower endogenous androgens predict central adiposity in men. Ann Epidemiol (1992) 1.32
Real-time quantification of fatty acid uptake using a novel fluorescence assay. J Lipid Res (2004) 1.21
Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. J Clin Endocrinol Metab (2004) 1.21
Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: effects of testosterone. J Clin Endocrinol Metab (1996) 1.18
Increased CUG triplet repeat-binding protein-1 predisposes to impaired adipogenesis with aging. J Biol Chem (2006) 1.13
Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues. Eur J Med (1992) 1.13
Obesity, body fat distribution and sex hormones in men. Int J Obes Relat Metab Disord (1993) 1.11
Cellularity in different regions of adipose tissue in young men and women. Metabolism (1972) 1.10
Fat depot origin affects fatty acid handling in cultured rat and human preadipocytes. Am J Physiol Endocrinol Metab (2001) 1.09
Dihydrotestosterone treatment results in obesity and altered lipid metabolism in orchidectomized mice. Obesity (Silver Spring) (2006) 1.04
The effects of androgens and estrogens on preadipocyte proliferation in human adipose tissue: influence of gender and site. J Clin Endocrinol Metab (2001) 1.04
Varying capacities for replication of rat adipocyte precursor clones and adipose tissue growth. J Clin Invest (1989) 0.98
Genetic aspects of susceptibility to obesity and related dyslipidemias. Mol Cell Biochem (1992) 0.98
Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity. J Clin Endocrinol Metab (2006) 0.96
Effects of testosterone on fat cell lipolysis. Species differences and possible role in polycystic ovarian syndrome. Biochimie (2005) 0.90
Direct effects of testosterone, 17 beta-estradiol, and progesterone on adrenergic regulation in cultured brown adipocytes: potential mechanism for gender-dependent thermogenesis. Endocrinology (2003) 0.89
Regulation of adenosine 5',monophosphate-activated protein kinase and lipogenesis by androgens contributes to visceral obesity in an estrogen-deficient state. Endocrinology (2006) 0.88
Growth of adipose tissue in infants, children and adolescents: variations in growth disorders. Int J Obes (1981) 0.88
Gene expression analyses in cynomolgus monkeys provides mechanistic insight into high-density lipoprotein-cholesterol reduction by androgens in primates. Endocrinology (2008) 0.87
Adipose tissue cellularity in man: the relationship between fat cell size and number, the mass and distribution of body fat and the history of weight gain and loss. Int J Obes (1982) 0.87
Tetrahydrogestrinone is an androgenic steroid that stimulates androgen receptor-mediated, myogenic differentiation in C3H10T1/2 multipotent mesenchymal cells and promotes muscle accretion in orchidectomized male rats. Endocrinology (2005) 0.85
Transcription, adipocyte differentiation, and obesity. J Mol Med (Berl) (1996) 0.85
Mutually antagonistic effects of androgen and activin in the regulation of prostate cancer cell growth. Mol Endocrinol (2003) 0.78
Modulation by sex hormones of the membranous transducing system regulating fatty acid mobilization in adipose tissue. Prostaglandins Leukot Essent Fatty Acids (1993) 0.77
Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA (2009) 13.00
Adverse events associated with testosterone administration. N Engl J Med (2010) 10.94
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature (2011) 8.45
Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med (2009) 7.55
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc (2011) 5.96
Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals. J Biol Chem (2007) 4.58
Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial. Ann Intern Med (2012) 4.18
Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab (2008) 3.78
Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat. Proc Natl Acad Sci U S A (2010) 3.54
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest (2013) 3.47
Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab (2010) 3.40
Fat tissue, aging, and cellular senescence. Aging Cell (2010) 3.34
Retinaldehyde represses adipogenesis and diet-induced obesity. Nat Med (2007) 3.18
Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci (2005) 3.14
Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am J Physiol Endocrinol Metab (2006) 3.03
Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol (2013) 2.47
B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci U S A (2013) 2.47
The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease. Neuron (2003) 2.43
Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A (2004) 2.41
Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc (2011) 2.34
Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance. Cell Metab (2008) 2.28
Interdisciplinary inpatient care for elderly people with hip fracture: a randomized controlled trial. CMAJ (2002) 2.25
Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am J Physiol Regul Integr Comp Physiol (2002) 2.23
Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc Natl Acad Sci U S A (2010) 2.17
Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. Am J Physiol Endocrinol Metab (2004) 2.16
AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol (2010) 2.11
Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab (2009) 2.08
Critical illness in children with influenza A/pH1N1 2009 infection in Canada. Pediatr Crit Care Med (2010) 2.08
Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family. J Lipid Res (2004) 2.08
Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial. Pain (2015) 2.01
Fat depot-specific characteristics are retained in strains derived from single human preadipocytes. Diabetes (2006) 1.99
Systematic expression profiling of the mouse transcriptome using RIKEN cDNA microarrays. Genome Res (2003) 1.98
Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am J Physiol Endocrinol Metab (2003) 1.98
Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 1.91
Adipogenesis and aging: does aging make fat go MAD? Exp Gerontol (2002) 1.90
Ascertainment of Testosterone Prescribing Practices in the VA. Med Care (2015) 1.89
Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J Bone Miner Res (2011) 1.83
Aging in adipocytes: potential impact of inherent, depot-specific mechanisms. Exp Gerontol (2007) 1.81
High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol (2011) 1.81
Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab (2007) 1.77
Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab (2003) 1.74
Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology (2003) 1.74
Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals. Am J Cardiol (2011) 1.65
Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis. Blood (2011) 1.64
Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. Obesity (Silver Spring) (2008) 1.63
A survey of stated physician practices and beliefs on the use of steroids in pediatric fluid and/or vasoactive infusion-dependent shock. Pediatr Crit Care Med (2013) 1.63
Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat Clin Pract Endocrinol Metab (2006) 1.63
Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study. J Clin Endocrinol Metab (2010) 1.62
Targeting the skeletal muscle-metabolism axis in prostate-cancer therapy. N Engl J Med (2012) 1.61
Influence of sex and hormone status on circulating natriuretic peptides. J Am Coll Cardiol (2011) 1.61
Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. J Clin Endocrinol Metab (2003) 1.57
Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells. Endocrinology (2005) 1.56
Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab (2002) 1.54
Quality of reporting of surveys in critical care journals: a methodologic review. Crit Care Med (2012) 1.53
Role of microRNA processing in adipose tissue in stress defense and longevity. Cell Metab (2012) 1.52
Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1beta/erbB4 signaling. J Biol Chem (2004) 1.52
Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc (2010) 1.51
Early-life sodium exposure unmasks susceptibility to stroke in hyperlipidemic, hypertensive heterozygous Tg25 rats transgenic for human cholesteryl ester transfer protein. Circulation (2009) 1.51
Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. J Clin Endocrinol Metab (2011) 1.50
DNA extraction procedures meaningfully influence qPCR-based mtDNA copy number determination. Mitochondrion (2009) 1.50
Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab (2010) 1.50
Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children. Cochrane Database Syst Rev (2014) 1.49
Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss. Am J Physiol Endocrinol Metab (2008) 1.46
The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials (2014) 1.46
Genetic determinants of serum testosterone concentrations in men. PLoS Genet (2011) 1.45
Effect of testosterone administration on liver fat in older men with mobility limitation: results from a randomized controlled trial. J Gerontol A Biol Sci Med Sci (2013) 1.44
Androgen supplementation in older women: too much hype, not enough data. J Am Geriatr Soc (2002) 1.43
Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence. Diabetes (2010) 1.43
Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation. J Gerontol A Biol Sci Med Sci (2011) 1.43
Testosterone and growth hormone improve body composition and muscle performance in older men. J Clin Endocrinol Metab (2009) 1.40
Serum androgen levels in black, Hispanic, and white men. J Clin Endocrinol Metab (2006) 1.40
Cell-specific mitotic defect and dyserythropoiesis associated with erythroid band 3 deficiency. Nat Genet (2003) 1.40
Epidemiology of uninvestigated and functional dyspepsia in Asia: facts and fiction. J Neurogastroenterol Motil (2011) 1.39
Neuregulin-1alpha and beta isoform expression in cardiac microvascular endothelial cells and function in cardiac myocytes in vitro. Exp Cell Res (2005) 1.37
Sex- and depot-dependent differences in adipogenesis in normal-weight humans. Obesity (Silver Spring) (2010) 1.37
Tests of muscle strength and physical function: reliability and discrimination of performance in younger and older men and older men with mobility limitations. J Am Geriatr Soc (2008) 1.37
Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment. J Clin Endocrinol Metab (2004) 1.36
The Lip lipoprotein from Neisseria gonorrhoeae stimulates cytokine release and NF-kappaB activation in epithelial cells in a Toll-like receptor 2-dependent manner. J Biol Chem (2003) 1.35
A solid-state NMR study of phospholipid-cholesterol interactions: sphingomyelin-cholesterol binary systems. Biophys J (2002) 1.35
Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev (2013) 1.33
Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. Am J Physiol Endocrinol Metab (2003) 1.33
The effects of myostatin on adipogenic differentiation of human bone marrow-derived mesenchymal stem cells are mediated through cross-communication between Smad3 and Wnt/beta-catenin signaling pathways. J Biol Chem (2008) 1.32
Testosterone action on skeletal muscle. Curr Opin Clin Nutr Metab Care (2004) 1.32
Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men. J Clin Endocrinol Metab (2006) 1.31
Activin a plays a critical role in proliferation and differentiation of human adipose progenitors. Diabetes (2010) 1.31
How fatty acids of different chain length enter and leave cells by free diffusion. Prostaglandins Leukot Essent Fatty Acids (2006) 1.31